Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Thursday's Intraday Session

Author: Benzinga Insights | May 23, 2024 12:31pm

Gainers

  • OneMedNet (NASDAQ:ONMD) shares moved upwards by 118.4% to $1.07 during Thursday's regular session. The market value of their outstanding shares is at $25.5 million.
  • Renovaro (NASDAQ:RENB) stock rose 46.79% to $1.38. The company's market cap stands at $203.5 million.
  • Altamira Therapeutics (NASDAQ:CYTO) shares increased by 29.37% to $1.85. The company's market cap stands at $4.1 million.
  • Purple Biotech (NASDAQ:PPBT) stock rose 23.44% to $0.84. The company's market cap stands at $21.9 million. As per the press release, Q1 earnings came out 2 days ago.
  • P3 Health Partners (NASDAQ:PIII) stock increased by 23.04% to $0.62. The market value of their outstanding shares is at $73.8 million.
  • Qilian Intl Hldg Gr (NASDAQ:QLI) stock moved upwards by 22.39% to $0.71. The market value of their outstanding shares is at $25.3 million.

Losers

  • SILO Pharma (NASDAQ:SILO) shares fell 17.8% to $1.89 during Thursday's regular session. The company's market cap stands at $5.2 million.
  • Cue Health (NASDAQ:HLTH) shares fell 16.92% to $0.09. The market value of their outstanding shares is at $14.1 million.
  • Protagenic Therapeutics (NASDAQ:PTIX) shares declined by 16.08% to $1.51. The company's market cap stands at $6.6 million.
  • Cytokinetics (NASDAQ:CYTK) shares decreased by 15.51% to $50.05. The market value of their outstanding shares is at $5.2 billion.
  • SAB Biotherapeutics (NASDAQ:SABS) shares fell 15.5% to $2.4. The market value of their outstanding shares is at $22.1 million. As per the news, the Q1 earnings report came out 3 days ago.
  • DermTech (NASDAQ:DMTK) stock declined by 14.05% to $0.36. The company's market cap stands at $12.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: CYTK CYTO DMTK HLTH ONMD PIII PPBT PTIX QLI RENB SABS SILO